Astrivax
astrivax.com
Actively hiring
Cell & Gene Therapy
Health Care
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Our Astrivax Therapeutics team is developing a vaccine technology platform and bringing the first immunotherapies into clinical development.
News
AstriVax begins clinical development of AVX70371, a hepatitis B immunotherapy using Launch-iT technology
AstriVax begins clinical development of AVX70371, a hepatitis B immunotherapy using Launch-iT technology
Read more
Report
AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology
Third asset to advance into clinical trials, validating broad potential of Launch-iT platform
Read more
Report
Astrivax Therapeutics Initiates Clinical Development Of AVX70371, A Hepatitis B Immunotherapy Using Launch-It Technology
Read more
Report
AstriVax enters clinical phase with its novel vaccine platform technology
The first participants have been dosed in SAFYR, a Phase I clinical trial to test the safety and efficacy of two prophylactic vaccines developed with AstriVax technology. The study will also provide clinical proof of concept for the company's platform tec
Read more
Report
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning
Dr. Fanning brings a wealth of experience in creating infectious disease pipelines by internal R&D and licensing As the CBO of AstriVax, he will lead the company's business development, including partnerships
Read more
Report
Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Read more
Report